The latest closing stock price for CRISPR Therapeutics AG as of January 21, 2025 is 41.51.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $1,946 today, roughly 2 times their original investment - a 14.46% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 91.10, which is 119.5% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 36.52, which is 12% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 55.47.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $1,946 today, roughly 2 times their original investment - a 14.46% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 91.10, which is 119.5% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 36.52, which is 12% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 55.47.